Research on Decreasing the Intestinal Carriage of Antibiotic Resistant Bacteria

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 3122

Special Issue Editor


E-Mail Website
Guest Editor
Microbiotes Hosts Antibiotics and bacterial Resistances (MiHAR), University of Nantes, Nantes, France
Interests: decreasing the intestinal carriage of multidrug resistant bacteria with prebiotic and new probiotics

Special Issue Information

Dear Colleagues,

The intestinal microbiota is a major reservoir of multidrug-resistant bacteria (MDRB). Intestinal colonization by MDRB is promoted by intestinal dysbiosis and may evolve from an asymptomatic carriage to various infections including urinary, gastrointestinal and bloodstream infections. Furthermore, the intestinal carriage of MDRB can lead to environmental contamination and transmission to healthy or diseased subjects. Hence, treatments to decrease this carriage are crucial in order to limit the global spread of antimicrobial resistance. Various strategies have been assessed, but none has proved to be effective so far.

The aim of this Issue is to explore new approaches able to fight such a carriage of MDRB, particularly carbapenem and ESBL-producing Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae, but also vancomycin-resistant enterococci and other relevant species. A diversity of strategies will be welcome: for example, the use of prebiotics, of probiotics (in particular new probiotics), the development of new quorum-sensing inhibitors, the synthesis of new prodrugs to specifically target MDRB, the use of bacteriophages, fecal transplantation, the beneficial effect of some diets, etc. Articles on the better use of antibiotics will also be considered, particularly those on the methodologies able to prevent intestinal dysbiosis.

Prof. Dr. Michel Dion
Guest Editor

Keywords

  • prebiotic
  • probiotic
  • antibiotic-resistant bacteria
  • intestinal carriage
  • quorum-sensing inhibitor
  • bacteriophage
  • prodrug
  • E. coli
  • K. pneumoniae
  • enterococci

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 2785 KiB  
Article
Protective Effect of Novel Lactobacillus plantarum KC3 Isolated from Fermented Kimchi on Gut and Respiratory Disorders
by Min-Seon Park, Yu-Jeong Kim, Han-Jae Shin, Yoo Jin Kwon, Jaeryang Chu, Inock Lee, Kyung Hwan Kim, Byoung Kook Kim, Seung-Hyung Kim, Hwi Won Seo and Tae-Won Kim
Microorganisms 2023, 11(4), 967; https://doi.org/10.3390/microorganisms11040967 - 7 Apr 2023
Cited by 6 | Viewed by 2694
Abstract
Probiotics have been shown to possess anti-inflammatory effects in the gut by directly reducing the production of pro-inflammatory cytokines and by secreting anti-inflammatory molecules. However, their systemic anti-inflammatory effects have not been thoroughly investigated. In this study, we aimed to develop probiotics that [...] Read more.
Probiotics have been shown to possess anti-inflammatory effects in the gut by directly reducing the production of pro-inflammatory cytokines and by secreting anti-inflammatory molecules. However, their systemic anti-inflammatory effects have not been thoroughly investigated. In this study, we aimed to develop probiotics that have efficacy in both intestinal and lung inflammation. Lactobacillus plantarum KC3 (KC3), which was isolated from kimchi, was selected as a pre-candidate based on its inhibitory effects on the production of pro-inflammatory cytokines in vitro. To further validate the effectiveness of KC3, we used ear edema, DSS-induced colitis, and ambient particulate-matter-induced lung inflammation models. First, KC3 exhibited direct anti-inflammatory effects on intestinal cells with the inhibition of IL-1β and TNF-α production. Additionally, KC3 treatment alleviated ear edema and DSS-induced colic inflammation, improving colon length and increasing the number of regulatory T cells. Beyond its local intestinal anti-inflammatory activity, KC3 inhibited pro-inflammatory cytokines in the bronchoalveolar fluid and prevented neutrophil infiltration in the lungs. These results suggest that KC3 could be a potential functional ingredient with respiratory protective effects against air-pollutant-derived inflammation, as well as for the treatment of local gut disorders. Full article
Show Figures

Figure 1

Back to TopTop